Insider · CIK 0002143905
Vincent Paul Liptak
Files at BLSM (BlossomHill Therapeutics, Inc.). First filing Aug 10, 2026, latest Aug 10, 2026.
In brief
Vincent Paul Liptak files SEC Form 4 as officer at BLSM (BlossomHill Therapeutics, Inc.). Since Aug 10, 2026, Vincent Paul Liptak has reported 1 open-market buy worth $75k and 0 open-market sells worth $0, the latest filed on Aug 10, 2026.
A track record needs three past buys with six months of prices behind them; Vincent Paul Liptak has 0, so none is measured yet.
The newest scored trade: bought $75k of BLSM on Aug 7, 2026, filed Aug 10, 2026, scored 38 (weak). In the last 12 months: 1 buy worth $75k and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BLSM: BlossomHill Therapeutics, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 38Weak | BlossomHill Therapeutics, Inc. | $75k 4,700 shares | +4% | - |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BLSM BlossomHill Therapeutics, Inc. | POpen-market purchase Common Stock | +2,500 | $15.80 | $40k | 109,212 | Aug 10, 2026 |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | POpen-market purchase Common Stock | +2,200 | $16.00 | $35k | 111,412 | Aug 10, 2026 |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | CConversion Common Stockindirect: By Walter T. Liptak Revocable Trust | +22,687 | - | - | 22,687 | Aug 10, 2026 |
| Aug 6, 2026 | BLSM BlossomHill Therapeutics, Inc. | AGrant or award Employee Stock Option (Right to Buy)derivative | +46,561 | $0.00 | $0 | 46,561 | Aug 10, 2026 |
| Aug 10, 2026 | BLSM BlossomHill Therapeutics, Inc. | CConversion Series B Preferred Stockderivativeindirect: By Walter T. Liptak Revocable Trust | -22,687 | - | - | 0 | Aug 10, 2026 |
Questions about Vincent Paul Liptak
Answered from the filings on this page, as of the latest one.
Is Vincent Paul Liptak buying or selling?
In the last 12 months Vincent Paul Liptak reported 1 open-market buy worth $75k and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $75k of BLSM on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Vincent Paul Liptak's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Vincent Paul Liptak has 0.
Where does Vincent Paul Liptak file Form 4?
Vincent Paul Liptak has filed Form 4 at BLSM (BlossomHill Therapeutics, Inc.) as General Counsel. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.